Octreotide Pamoate
Refractory Ascites
University of AlbertaPhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Refractory Ascites cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
NORMAL HUMAN SERUM ALBUMIN University of Alberta | Phase 2/3 | B |
L-Ornithine-L-Aspartate Air Force Military Medical University, China | Phase 2/3 | B |
Midodrine National Liver Institute, Egypt | Phase 2/3 | B |
Glutamine University of Arkansas | D |
Same molecule, other indications
Octreotide Pamoate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →